XDEB:XETRA:XETRA-db x-trackers MSCI World Minimum Volatility UCITS DR 1C (EUR)

ETF | Others |

Last Closing

USD 41.57

Change

+0.22 (+0.53)%

Market Cap

USD 0.42B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.34 (+0.68%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.11 (+0.69%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.18 (+0.69%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.17 (+0.60%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.30 (+1.23%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.13 (+0.28%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+1.44 (+1.02%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.31 (+0.61%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.48 (+0.49%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.02 (+0.54%)

USD 80.38B

ETFs Containing XDEB:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.15% 83% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.15% 82% B 80% B-
Trailing 12 Months  
Capital Gain 14.71% 65% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.71% 65% D 65% D
Trailing 5 Years  
Capital Gain 35.41% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.41% 56% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 6.16% 55% F 55% F
Dividend Return 6.16% 54% F 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.90% 64% D 71% C-
Risk Adjusted Return 69.17% 70% C- 73% C
Market Capitalization 0.42B 62% D 54% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike